Of note, it has also been hypothesized that MPN-associated clonal thrombocythemia may sustain an intriguing “platelet–cancer loop”, as pathologic platelets could readily suppress specific T cells by means of TGF-β release [112]. This evidence concerns the gene TGFB1 and myeloproliferative disorder.